In addition, we showed that in the group of patients with type 1 diabetes with anti-EBNA-1 antibodies in the IgG class, the percentage of CD3+CD4+IL-10+ T cells was significantly higher (p = 0.033; Figure 6C). This evidence concerns the gene CD4 and type 1 diabetes mellitus.